Claudio Giorlandino
Sapienza University of Rome
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Claudio Giorlandino.
Proteomics Clinical Applications | 2011
Marzia Perluigi; Fabio Di Domenico; Ada Fiorini; Annalisa Cocciolo; Alessandra Giorgi; Cesira Foppoli; D. Allan Butterfield; Maurizio Giorlandino; Claudio Giorlandino; M. Eugenia Schininà; Raffaella Coccia
Purpose: The present study aims to evaluate a set of oxidative stress biomarkers in the amniotic fluid (AF) of women carrying Down syndrome (DS) fetuses that could prove in vivo the early occurrence of oxidative damage in DS.
Fertility and Sterility | 1998
Claudio Giorlandino; Graziella Calugi; Laura Iaconianni; M.Luisa Santoro; Assunta Lippa
OBJECTIVE To determine whether sperm aneuploidy can lead to abortion. DESIGN Clinical study. SETTING Couples with reproductive problems evaluated in a private diagnostic laboratory. PATIENT(S) Two men whose wives had histories of multiple abortions. INTERVENTION(S) Whole and Percoll-processed semen samples were analyzed. MAIN OUTCOME MEASURE(S) The results of fluorescence in situ hybridization. RESULT(S) Aneuploidy rates in Percoll-processed samples were higher than those found in whole specimens. Aneuploid spermatozoa also displayed greater motility. CONCLUSION(S) Sperm aneuploidy should be studied before and after Percoll capacitation in all couples with unexplained infertility.
Prenatal Diagnosis | 1996
Claudio Giorlandino; Giovanni Gambuzza; Paolo D'Alessio; Maria Luisa Santoro; Paolo Gentili; Antonio Vizzone
The aim of the present study was to evaluate blood contamination of the amniotic fluid collected in 20 patients undergoing a second amniocentesis performed 2 weeks after a first procedure that had failed due to Pseudomonas aeruginosa contamination of the cell cultures. Red blood cell and haemoglobin concentrations in the amniotic fluid were significantly higher in patients who had undergone a transplacental procedure compared with patients in whom the placenta was not traversed with the needle. For both groups, blood contamination of the amniotic fluid was significantly higher compared with a control group of 20 patients undergoing amniocentesis for the first time. Significant blood contamination of the amniotic fluid after amniocentesis occurs in every instance if evaluated at a ‘second‐look’ procedure; the blood contamination is higher when an anterior placenta is traversed with the needle. The clinical significance of these findings needs to be further evaluated.
Prenatal Diagnosis | 2009
Claudio Giorlandino; Pietro Cignini; Marco Cini; Cristiana Brizzi; Ornella Carcioppolo; Vincenzo Milite; Claudio Coco; Paolo Gentili; Lucia Mangiafico; Alvaro Mesoraca; Domenico Bizzoco; Ivan Gabrielli; Luisa Mobili
To compare procedure‐related pregnancy loss after second‐trimester genetic amniocentesis in women given an antibiotic prophylaxis and controls.
Journal of Maternal-fetal & Neonatal Medicine | 2010
Pietro Cignini; Laura D'Emidio; Francesco Padula; Alessandra Girgenti; Silvia Battistoni; Roberto Vigna; Riccardo Franco; Diego Rossetti; Maurizio Giorlandino; Claudio Giorlandino
Objective. To evaluate the role of a dedicated neurosonographer in prenatal diagnosis of isolated complete agenesis of the corpus callosum (iCACC) and to asses the postnatal outcome of these infants. Methods. Prospective study between January 2004 to December 2004 at Fetal Maternal Medical Centre ‘Artemisia’, Rome, Italy. A detailed ultrasound scan was performed in fetuses affected by iCACC by a dedicated fetal neurosonographer (CG). In all cases, magnetic resonance imaging (MRI) within 5 weeks and 13–15 months after birth was performed. A comparison was made between prenatal findings following the ultrasound scan and postnatal MRI. In these cases, a follow-up of 4-years was performed with a neurological evaluation. Results. Among 23 cases of ACC diagnosed at our centre in the study period, CACC was diagnosed in 17 fetuses. Two were then excluded due to associated malformations, one was lost at follow-up and one patient opted to terminate her pregnancy. Newborn MRI confirmed the ultrasonographic diagnosis of iCACC in all 13 cases. A regular development was present in 92.3% of prenatally diagnosed iCACC. Conclusion. A dedicated neurosonographer could diagnose the iCACC with the same accuracy as MRI and in up to 90% of cases the newborn will have a regular development.
Journal of Ultrasound in Medicine | 2014
Pietro Cignini; Francesco Padula; Maurizio Giorlandino; Pierpaolo Brutti; Marco Alfò; Diana Giannarelli; Maria Luisa Mastrandrea; Laura D'Emidio; Lorenzo Vacca; Alessia Aloisi; Claudio Giorlandino
The purpose of this study was to establish reference charts for fetal corpus callosum length in a convenience sample.
Journal of Ultrasound in Medicine | 2015
Francesco Padula; Ferdinando Antonio Gulino; Stella Capriglione; Maurizio Giorlandino; Pietro Cignini; Maria Luisa Mastrandrea; Laura D'Emidio; Claudio Giorlandino
The purpose of this study was to estimate the rate of incomplete fetal anatomic surveys during a second‐trimester scan due to an unfavorable fetal position in a nonobese population.
Taiwanese Journal of Obstetrics & Gynecology | 2016
Francesco Libotte; Domenico Bizzoco; Ivan Gabrielli; Alvaro Mesoraca; Pietro Cignini; Salvatore Giovanni Vitale; Ilaria Marilli; Ferdinando Antonio Gulino; Agnese Maria Chiara Rapisarda; Claudio Giorlandino
OBJECTIVE Pallister-Killian syndrome (PKS) is a rare, sporadic genetic disorder caused by mosaic tetrasomy of the short arm of chromosome 12 (12p). Clinically, PKS is characterized by several systemic abnormalities, such as intellectual impairment, hearing loss, epilepsy, hypotonia, craniofacial dysmorphism, pigmentary skin anomalies, epilepsy, and a variety of congenital malformations. Prenatally, PKS can be suspected in the presence of ultrasound anomalies: diaphragmatic hernia, rhizomelic micromelia, hydrops fetalis, fetal overweight, ventriculomegaly in the central nervous system, congenital heart defects, or absent visualization of the stomach. In all these cases, a detailed genetic study is required. PKS is diagnosed by prenatal genetic analysis through chorionic villus sampling, genetic amniocentesis, and cordocentesis. CASE REPORT We report two cases of PKS with prenatal diagnosis of isochromosome 12p made by cytogenetic studies. The first case is of a 36-year-old pregnant woman who underwent genetic chorionic villus sampling at 13th weeks of gestation after 1st trimester prenatal ultrasound revealed clinical features of PKS: flat nasal bridge and fetal hydrops. The second case is of a 32-year-old pregnant woman with genetic amniocentesis at 17th weeks of gestation that showed mos46,XX[21]/47,XX,+i(12p) associated to PKS. CONCLUSION New molecular cytogenetic techniques array comparative genomic hybridization and fluorescence in-situ hybridization in association with conventional karyotype are pivotal innovative tools to search for chromosomic anomalies and for a complete prenatal diagnosis, especially in cases such as PKS where array comparative genomic hybridization analysis alone could not show mosaicism of i(12p).
journal of Clinical Case Reports | 2014
Claudio Dello Russo; Gianluca Di Giacomo; Alvaro Mesoraca; Domenico Bizzoco; Megan R McCluskey; Arianna Paganelli; Claudio Giorlandino
BACKGROUND prenatal genetic diagnosis of rare disorders is undergoing in recent years a significant enhancement through the application of methods of massive parallel sequencing. Despite the quantity and quality of the data produced, just few analytical tools and software have been developed in order to identify structural and numerical chromosomal anomalies through NGS, mostly not compatible with benchtop NGS platform and routine clinical diagnosis. METHODS we developed technical, bioinformatic, interpretive and validation pipelines for Next Generation Sequencing to identify SNPs, indels, aneuploidies, and CNVs (Copy Number Variations). RESULTS we show a new targeted resequencing approach applied to prenatal diagnosis. For sample processing we used an enrichment method for 4,813 genes library preparation; after sequencing our bioinformatic pipelines allowed both SNPs analysis for approximately thirty diseases or diseases family involved in fetus development and numerical chromosomal anomalies screening. CONCLUSIONS results obtained are compatible with those obtained through the gold standard technique, aCGH array, moreover allowing identification of genes involved in chromosome deletions or duplications and exclusion of point mutation on allele not affected by chromosome aberrations.
Lasers in Medical Science | 2017
Francesco Padula; Stella Capriglione; Paola Iaconianni; Simona Gatti; Assunta Lippa; Salvatrice Elisa Minutolo; Diana Giannarelli; Claudio Giorlandino
Oocytes and early embryos are surrounded by a 13–15-μm thick of zona pellucida layer that is involved in the formation of binding with the spermatozoa, hardening process, induction of acrosome reaction, egg fusion, and prevention of polyspermy [1]. Its function becomes less important once the structural junctions between blastomeres in the compaction process are established [2]. Hatching is the physiological process in which the embryo, at the blastocyst stage, comes out of the zona pellucida. This process is a fundamental prerequisite for implantation [3]. Several studies indicate that a zona pellucida thinning is an active process of embryo development already in the early stages [4], and it was demonstrated that not-cleaved embryos do not show changes in thickness of the zona pellucida in culture [5]. The inability of the blastocyst to hatch from the zona pellucida may be one of the factors involved in the high implant failure rate in human in vitro fertilization (IVF) [6], maybe due to a loss of elasticity of the zona pellucida in IVF embryos, similarly to an aging process [7] and to a reduced sensitivity to low pH. Assisted hatching (AH) is the methodology used in IVF to mimic the normal hatching stage of embryonic development and it should increase the implant rate among poor prognosis patients or on embryos noted to have a thick zona pellucida [8, 9]. It has been suggested that AH facilitates the implantation because it allows an early contact between embryo and endometrial tissues and exposing it to growth factors fundamental for the subsequent stages of the blastocyst’s development [10]. AH can be obtained by different methods: mechanical, chemical, or by laser energy. The mechanical techniques are performed by micromanipulator stabilizing the embryo by a holding pipette while a microneedle is pushed tangentially through the zona pellucida. This technique is quick to perform but the size of the hole cannot be standardized. The chemical approach is performed by preloading the microneedle with acid Tyrode and injecting it in a blastomere-free area. This technique requires a very high skill in handling the micromanipulator to perform it as quick as possible to prevent an unnecessary exposure of the embryo to the toxic acid solution. Laser-assisted hatching (LAH) can be applied through different techniques: drilling that is an artificial hole of the zona pellucida, just to the opposite side where the embryo is formed, and thinning that is just a thinning of the outer protective glycoprotein layer. LAH has the benefit of a non-contact mode on the embryos and is the easiest approach to perform. However, although many works compare the various methods [11], there are insufficient data that compare the different techniques within the same method [12]. The primary aim of this work is to retrospectively compare the implant rate after the application of two different techniques (drilling and thinning) obtained by LAH. * Stella Capriglione [email protected]